Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 5 | $461,215 |
| Sells | 6 | $6,123,021 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 15 Nov 2024 | Sale | 8,530 | 25.0218 | 213,436 | I |
| 19 Nov 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 18 Nov 2024 | Sale | 33,273 | 25.0786 | 834,440 | I |
| 15 Nov 2024 16:36 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 13 Nov 2024 | Sale | 1,066 | 25.0043 | 26,655 | I |
| 15 Nov 2024 16:36 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 14 Nov 2024 | Sale | 9,832 | 25.0057 | 245,856 | I |
| 01 Oct 2024 17:23 | NAMS | NewAmsterdam Pharma Co N.V. | KOOIJ LOUISE FREDERIKA | Chief Accounting Officer | 01 Oct 2024 | Sale | 45,000 | 15.72 | 707,400 | D |
| 30 Sep 2024 17:22 | NAMS | NewAmsterdam Pharma Co N.V. | AUDET JULIETTE BERANGERE | Chief Business Officer | 26 Sep 2024 | Purchase | 1,104 | 15.7 | 17,333 | D |
| 22 Aug 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | DAVIDSON MICHAEL H. | Chief Executive Officer | 20 Aug 2024 | Purchase | 5,000 | 16.27 | 81,350 | D |
| 24 Jun 2024 08:30 | NAMS | NewAmsterdam Pharma Co N.V. | DAVIDSON MICHAEL H. | Chief Executive Officer | 20 Jun 2024 | Purchase | 5,000 | 17.2617 | 86,308 | D |
| 28 Mar 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | TOPPER JAMES N | Director | 26 Mar 2024 | Purchase | 8,429 | 21.5 | 181,224 | I |
| 27 Mar 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | KASTELEIN JOHANNES JACOB PIETER | Chief Scientific Officer | 26 Mar 2024 | Sale | 190,476 | 21.5 | 4,095,234 | I |
| 21 Feb 2024 17:00 | NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Director | 13 Feb 2024 | Purchase | 5,000 | 19 | 95,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)